ici 118551 has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrionuevo, M; Cenarruzabeitia, E; MartÃnez, JA; Milagro, FI | 1 |
| Gousse, A; Latifpour, J; Weiss, RM; Yoshida, M | 1 |
2 other study(ies) available for ici 118551 and Alloxan Diabetes
| Article | Year |
|---|---|
Potential anti-diabetic applications of a new molecule with affinity for beta 3-adrenoceptors.
Topics: Adipose Tissue; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Benzyl Alcohols; Blood Glucose; Diabetes Mellitus, Experimental; Esophagus; Female; Guinea Pigs; Imidazoles; Insulin; Muscle Relaxation; Muscle, Smooth; Oxygen Consumption; Propanolamines; Rats; Rats, Wistar; Triglycerides | 1996 |
Beta adrenergic receptor alterations in diabetic rat prostate: effects of insulin and dietary myoinositol.
Topics: Adrenergic beta-Antagonists; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dihydroalprenolol; Dose-Response Relationship, Drug; Drinking; Inositol; Insulin; Isoproterenol; Male; Organ Size; Propanolamines; Propranolol; Prostate; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Streptozocin; Urination | 1991 |